A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Heart Failure
Interventions
BIOLOGICAL

Placebo

S.C. Injection

BIOLOGICAL

XXB750 Low dose

S.C. Injection

BIOLOGICAL

XXB750 Medium Dose

S.C. Injection

BIOLOGICAL

XXB750 High Dose

S.C. Injection

DRUG

Sacubitril/valsartan

Tablet

Trial Locations (62)

1134

Novartis Investigative Site, Budapest

1233

Novartis Investigative Site, Sofia

1510

Novartis Investigative Site, Sofia

2500

Novartis Investigative Site, Kyustendil

4002

Novartis Investigative Site, Plovdiv

5300

Novartis Investigative Site, Gabrovo

5800

Novartis Investigative Site, Pleven

8230

Novartis Investigative Site, Balatonfüred

9010

Novartis Investigative Site, Varna

13347

Novartis Investigative Site, Berlin

15706

Novartis Investigative Site, Santiago de Compostela

20138

Novartis Investigative Site, Milan

20744

Anderson Medical Research, Ft. Washington

21005

Novartis Investigative Site, Huelva

23219

Dominion Medical Associates, Richmond

24105

Novartis Investigative Site, Kiel

25123

Novartis Investigative Site, Brescia

26871

Novartis Investigative Site, Papenburg

28041

Novartis Investigative Site, Madrid

28222

Novartis Investigative Site, Madrid

29010

Novartis Investigative Site, Málaga

30101

American Clinical Trials, Acworth

33014

Inpatient Research Clinical LLC, Miami Lakes

33170

Novartis Investigative Site, Pordenone

33449

Cardiology Partners Clinical Research Institute, Wellington

34149

Novartis Investigative Site, Trieste

34452

Nature Coast Clinical Research LLC, Inverness

35010

Novartis Investigative Site, Las Palmas de Gran Canaria

35801

Heart Center Research Llc, Huntsville

36305

SEC Clinical Research, Dothan

37388

Tennessee Center For Clinical Trials, Tullahoma

40447

Novartis Investigative Site, Taichung

40503

The Research Group, Lexington

44710

Aultman Hospital, Canton

45801

NexGen Research, Lima

45968

Novartis Investigative Site, Gladbeck

46010

Novartis Investigative Site, Valencia

46026

Novartis Investigative Site, Valencia

48084

Revival Research Institute, Troy

51065

Novartis Investigative Site, Cologne

67067

Novartis Investigative Site, Ludwigshafen

70403

Heart Clinic of Hammond, Hammond

74523

Novartis Investigative Site, Schwäbisch Hall

98125

Novartis Investigative Site, Messina

334003

Novartis Investigative Site, Bikaner

590010

Novartis Investigative Site, Belagavi

710061

Novartis Investigative Site, Xian

270 0

Novartis Investigative Site, Blagoevgrad

00133

Novartis Investigative Site, Roma

00168

Novartis Investigative Site, Roma

371 8511

Novartis Investigative Site, Maebashi

216-8511

Novartis Investigative Site, Kawasaki

252-0375

Novartis Investigative Site, Sagamihara

390-8621

Novartis Investigative Site, Matsumoto

1449-005

Novartis Investigative Site, Lisbon

4434 502

Novartis Investigative Site, Vila Nova de Gaia

040 01

Novartis Investigative Site, Košice

036 01

Novartis Investigative Site, Martin

089 01

Novartis Investigative Site, Svidník

085 01

Novartis Investigative Site, Bardejov

949 01

Novartis Investigative Site, Nitra

080 01

Novartis Investigative Site, Prešov

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY